Resultados de la búsqueda 251-260 of 14039 for Metabolic alkalosis

  1. The world's best hospital - Mayo Clinic

    Mayo Clinic is the No. 1 hospital in the world., with campuses in Arizona, Florida, and Minnesota.

  2. Síntomas y causas - Mayo Clinic

    Symptoms of polyendocrine metabolic syndrome (PMOS), often start around the time of the first menstrual period. Sometimes symptoms develop later after you have ...

  3. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The hostile TME can also drive CAR T-cells to functional exhaustion and metabolic dysfunction, thus blunting the therapeutic efficacy of CAR T-cells.[3] ...

  4. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The hostile TME can also drive CAR T-cells to functional exhaustion and metabolic dysfunction, thus blunting the therapeutic efficacy of CAR T-cells.[3] ...

  5. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The hostile TME can also drive CAR T-cells to functional exhaustion and metabolic dysfunction, thus blunting the therapeutic efficacy of CAR T-cells.[3] ...

  6. Tumores y adenomas pituitarios

    The Journal of Clinical Endocrinology & Metabolism. 2016; doi:10.1210/jc.2016-2118. Tritos NA, et al. Diagnosis and management of pituitary adenomas: A ...

  7. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The hostile TME can also drive CAR T-cells to functional exhaustion and metabolic dysfunction, thus blunting the therapeutic efficacy of CAR T-cells.[3] ...

  8. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The hostile TME can also drive CAR T-cells to functional exhaustion and metabolic dysfunction, thus blunting the therapeutic efficacy of CAR T-cells.[3] ...

  9. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The hostile TME can also drive CAR T-cells to functional exhaustion and metabolic dysfunction, thus blunting the therapeutic efficacy of CAR T-cells.[3] ...

  10. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The hostile TME can also drive CAR T-cells to functional exhaustion and metabolic dysfunction, thus blunting the therapeutic efficacy of CAR T-cells.[3] ...